Enantia is a speaker sponsor for the symposium
March 18th, 2021
This event will focus in innovative synthesis facilitating candidate discovery and overcoming the challenges of their scale up. These activities are carried out by Enantia in its Medicinal Chemistry and Process Chemistry departments respectively.
If you are interested in the chemical development of your candidates to optimize their activity, selectivity or toxicologic profile (among other properties) contact us to know more about our offer in Hit finding, H2L and LO programs.
Once a candidate is selected to be moved forward in the drug discovery process, one of Enantia’s main activities is the development of scalable routes of synthesis according to our clients’ requirements for a suitable scale up.
Contact us if you would like more information about any of our services.